Famotidine Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 10 mg, 20 mg
Reference Brands: Pepcid(US and EU)
Category:
Medical Aid
Famotidine tablets are H2 receptor antagonists that block histamine receptors in the stomach lining, reducing acid production. Benefits include relief from heartburn, GERD, and ulcers, promoting healing and preventing acid-related damage. They improve gastrointestinal comfort and reduce symptoms of acid reflux and gastrointestinal ulcers.
Famotidine tablets is available in Tablet
and strengths such as 10 mg, 20 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Famotidine tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Famotidine tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Famotidine tablets are approved in both the US and EU, supported by detailed dossiers demonstrating safety, efficacy, and manufacturing quality in compliance with GMP standards. In the US, branded products like Pepcid and generics are widely available. In the EU, famotidine is available as a generic medication and under similar brand names. Regulatory approval involves rigorous clinical evaluation and documentation. For comprehensive information on licensing, approved dossiers, and regulatory requirements for famotidine tablets, visit Pharmatradz. Stay updated on the latest regulatory developments and licensing processes for famotidine across global markets.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing